Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

648 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial.
Labhardt ND, Smit M, Petignat I, Perneger T, Marinosci A, Ustero P, Diniz Ribeiro MP, Ragozzino S, Nicoletti GJ, Faré PB, Andrey DO, Jacquerioz F, Lebowitz D, Agoritsas T, Meyer B, Spechbach H, Salamun J, Guessous I, Chappuis F, Kaiser L, Decosterd LA, Grinsztejn B, Bernasconi E, Cardoso SW, Calmy A, Team FTCS. Labhardt ND, et al. Among authors: bernasconi e. EClinicalMedicine. 2021 Dec;42:101188. doi: 10.1016/j.eclinm.2021.101188. Epub 2021 Nov 6. EClinicalMedicine. 2021. PMID: 34778734 Free PMC article.
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function.
di Iulio J, Fayet A, Arab-Alameddine M, Rotger M, Lubomirov R, Cavassini M, Furrer H, Günthard HF, Colombo S, Csajka C, Eap CB, Decosterd LA, Telenti A; Swiss HIV Cohort Study. di Iulio J, et al. Pharmacogenet Genomics. 2009 Apr;19(4):300-9. doi: 10.1097/FPC.0b013e328328d577. Pharmacogenet Genomics. 2009. PMID: 19238117
A randomized crossover study to compare efavirenz and etravirine treatment.
Nguyen A, Calmy A, Delhumeau C, Mercier IK, Cavassini M, Fayet-Mello A, Elzi L, Genné D, Rauch A, Bernasconi E, Hirschel B; Swiss HIV Cohort Study. Nguyen A, et al. Among authors: bernasconi e. AIDS. 2011 Jan 2;25(1):57-63. doi: 10.1097/QAD.0b013e32833f9f63. AIDS. 2011. PMID: 21076278 Clinical Trial.
Impact of a nurse vaccination program on hepatitis B immunity in a Swiss HIV clinic.
Boillat Blanco N, Probst A, Da Costa VW, Giulieri S, Bernasconi E, Calmy A, Elzi L, Rauch A, Weber R, Bertisch B, Cavassini M, Bochud PY. Boillat Blanco N, et al. Among authors: bernasconi e. J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):472-4. doi: 10.1097/QAI.0b013e318237915e. J Acquir Immune Defic Syndr. 2011. PMID: 21963937
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
Glass TR, Rotger M, Telenti A, Decosterd L, Csajka C, Bucher HC, Günthard HF, Rickenbach M, Nicca D, Hirschel B, Bernasconi E, Wandeler G, Battegay M, Marzolini C; Swiss HIV Cohort Study. Glass TR, et al. Among authors: bernasconi e. PLoS One. 2012;7(1):e29186. doi: 10.1371/journal.pone.0029186. Epub 2012 Jan 3. PLoS One. 2012. PMID: 22235271 Free PMC article.
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals.
Lubomirov R, Arab-Alameddine M, Rotger M, Fayet-Mello A, Martinez R, Guidi M, di Iulio J, Cavassini M, Günthard HF, Furrer H, Marzolini C, Bernasconi E, Calmy A, Buclin T, Decosterd LA, Csajka C, Telenti A; Swiss HIV Cohort Study. Lubomirov R, et al. Among authors: bernasconi e. Pharmacogenet Genomics. 2013 Jan;23(1):9-18. doi: 10.1097/FPC.0b013e32835ade82. Pharmacogenet Genomics. 2013. PMID: 23111422
648 results